l carnitine and dmso l-carnitine alleviates synovitis in knee osteoarthritis by regulating lipid accumulation mitochondrial function through the AMPK-ACC-CPT1 signaling pathway | Journal of Orthopaedic Surgery and Research L-Carnitine | Linus Pauling Institute
Description
SMD: Standardized mean dierence
342 Ongoing clinical trials (NCT02880410, NCT03022578, NCT03341806, and NCT03277638) are evaluating its efficacy, safety, and potential synergy with chemotherapy
Most providers recommend a minimum of three to six months to see meaningful changes in body composition and muscle
RELATED NEWS Look for solutions
doi:10.7150/ijbs.104311 This issue Cite Research Paper 1
